Laddar populära aktier...
Correction: ContextVision AB: Result of the offer to buy back own shares
ContextVision AB: Result of the offer to buy back own shares
ContextVision AB: Launch of offer to buy back own shares
Mandatory notification of trade – primary insider
Gerald Pötzsch, CEO of ContextVision, and Olof Sandén, Chairman of the Board of ContextVision has purchased shares in ContextVision.
KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMA I CONTEXTVISION AB (PUBL)
BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING OF CONTEXTVISION AB (PUBL)
Q3 interim report 2024 – Focus on internal efficiency and product development to drive long-term growth
ContextVision publishes Webcast for Q3 2024
KALLELSE TILL EXTRA BOLAGSSTÄMMA I CONTEXTVISION AB (PUBL)
Notice to the Extraordinary General Meeting in ContextVision AB (publ)
ContextVision publishes Webcast for Q2 2024
ContextVision AB: Q2 interim report 2024 - Strong cash position supports continued investment in Image and Data Quality
ContextVision AB: Delårsrapport Q2 2024 - Stark kassaposition stöder fortsatta investeringar i bild- och datakvalitet
Stockholm, Sweden, July 18, 2024 – ContextVision, a leading provider of medical image processing and analysis technology, is excited to anno...
ContextVision – Mandatory notification of trade – primary insider
ContextVision (publ), org. no. 556377-8900 (the "Company"), held its Annual General Meeting on May 14, 2024, at 13:00 at the company headqua...
ContextVision (publ), org.nr 556377-8900 (”Bolaget”), har hållit årsstämma den 14 maj 2024 kl.
ContextVision publishes Webcast for Q1 2024
ContextVision AB: Q1 interim report 2024 - Building for the future and leading innovation
ContextVisions årsredovisning för verksamhetsåret 2023 finns nu tillgänglig på www.
The shareholders of ContextVision AB (publ), corporate identity number 556377-8900, are hereby invited to the Annual General Meeting on Tues...
Aktieägarna i ContextVision AB (publ), org.nr 556377-8900, kallas till årsstämma tisdagen den 14 maj 2024, kl.
The annual report of ContextVision for the fiscal year 2023 is now available at www.
STOCKHOLM, SWEDEN / April 2024 / ContextVision, the global leader in image enhancement technology, will be presenting their latest innovati...
ContextVision publishes Webcast for Q4 2023
ContextVision AB: Year-end report 2023 – Underlying growth and scaling up the business
STOCKHOLM, SWEDEN / November 20, 2023 / At this year’s RSNA in Chicago, November 26-30, ContextVision puts their success story Altumira in t...
STOCKHOLM, SWEDEN / November 21, 2023 / Ever since they started out in 1983 in Linköping, Sweden, ContextVision’s innovative solutions have ...
With a record revenue and a solid EBITDA margin of 44% in Q3 as well as the first nine months, the company reaffirms its foundation for grow...
NEW CFO APPOINTED
STOCKHOLM – August 24, 2023 – ContextVision, a medical technology software company renowned for its expertise in image processing, continues...
Reference is made to record date announcement from ContextVision may 3rd 2023.
STOCKHOLM – May 3[rd], 2023 – ContextVision, a medical technology software company specializing in image processing and image analysis, toda...
Continued strong growth
ContextVision - Kallelse till årsstämma 2023
Årsredovisning 2022 – rekordförsäljning med fullt fokus på att växa kärnverksamheten
ContextVision – Invitation to Annual General Meeting 2023
Annual report 2022 – record sales with full focus on growing the core business
Strong Q4 and a record full year 2022
STOCKHOLM – Oct 20, 2022- ContextVision, a medical technology software company specializing in image processing and image analysis, today re...
Successfully focusing on core business
ContextVision announces appointment of Gerald Pötzsch as new CEO
ContextVision Annual General Meeting
ContextVision Presentation Q1 2022
STOCKHOLM – April 21, 2022 – ContextVision, a medical technology software company specializing in image processing and image analysis, today...
ContextVision – Invitation to Annual General Meeting 2022
ContextVision - Kallelse till årsstämma 2022
ContextVision presents Annual Report 2021
ContextVision presenterar Årsredovisning 2021
ContextVision shows strong momentum in Q4, leading to record sales for the year
ContextVision confirms the value of the upcoming dividend
ContextVision announces resolution regarding record date for dividend
ContextVision – new CFO appointed
INIFY Laboratories AB becomes an independent company
ContextVision Extraordinary General Meeting
Kallelse till extra bolagsstämma i ContextVision AB (Publ)
ContextVision to focus pathology efforts on the establishment of a fully AI-supported lab service
ContextVision - Aiming to build the company’s first modern pathology lab
INIFY Prostate® shown to accurately outline suspicious prostate cancer in study with two prominent medical centers
In the Pan-European multicenter clinical study FirstPath, INIFY Prostate produced highly accurate, robust and homogenous results at all site...
ContextVision: Assessing a Digital Pathology spin-off with a listing on Euronext Growth
ContextVision: Best ever sales within Medical Imaging and rewarding feedback from INIFY Prostate evaluations
ContextVision Annual General Meeting 2021
Progress in establishing reference centers within digital pathology
ContextVision – Kallelse till årsstämma 2021
ContextVision presenterar Årsredovisning 2020
ContextVision stock-based incentive program - share transactions
ContextVision’s Chairman of the Board Erik Danielsen declines re-election
ContextVision - invitation to company presentation
